Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
- Published In:
- Central-European journal of immunology, 43(4), 453-457 (2018)
- Database ID:
- RPEP-03797
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03797APA
Majewski, Karol; Kozłowska, Elżbieta; Żelechowska, Paulina; Brzezińska-Błaszczyk, Ewa. (2018). Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.. Central-European journal of immunology, 43(4), 453-457. https://doi.org/10.5114/ceji.2018.81355
MLA
Majewski, Karol, et al. "Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.." Central-European journal of immunology, 2018. https://doi.org/10.5114/ceji.2018.81355
RethinkPeptides
RethinkPeptides Research Database. "Serum concentrations of antimicrobial peptide cathelicidin L..." RPEP-03797. Retrieved from https://rethinkpeptides.com/research/majewski-2018-serum-concentrations-of-antimicrobial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.